Cleerly ISCHEMIA vs inHEART Models
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you need a non-invasive, AI-powered assessment of coronary artery disease (CAD) to determine vessel-level ischemia likelihood and characterize coronary plaque from CCTA scans. This tool is ideal for guiding personalized medical management and risk stratification in patients with suspected CAD, aiding in decisions about further diagnostic or interventional steps.
View Cleerly ISCHEMIA →Choose inHEART Models if…
Choose inHEART Models if you are planning or performing complex image-guided cardiac ablation procedures and require highly detailed, AI-driven 3D digital twin models of the heart. This tool is best suited for optimizing pre-procedural planning, enhancing intra-procedural guidance through seamless integration with electroanatomic mapping systems, and ultimately improving procedural efficiency and patient outcomes for arrhythmias.
View inHEART Models →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | inHEART Models |
|---|---|---|
| Pricing | Contact for details | Contact for pricing |
| Deployment | Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) | Cloud-based |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
inHEART ModelsinHEART Models emphasizes a streamlined 'Upload, Automate, Visualize' workflow and boasts seamless integration with major electroanatomic mapping systems, which is critical for its target users in cardiac ablation. This suggests a highly optimized and intuitive user experience for complex procedural planning. Cleerly also offers a web-based platform and integration, but inHEART's workflow appears more directly tailored for ease of use in its specific clinical context.
Clinical Value
inHEART ModelsinHEART Models presents compelling, quantifiable clinical benefits, including a potential 60% reduction in VT procedure times and a 38% reduction in VT recurrence rates, directly impacting patient outcomes and procedural efficiency. While Cleerly ISCHEMIA offers valuable non-invasive diagnostic capabilities like FFR estimation, inHEART's stated impact on complex interventional procedures provides a stronger, more measurable clinical value proposition.
Pricing & Value
TieBoth Cleerly ISCHEMIA and inHEART Models have non-publicly disclosed pricing, requiring direct contact with the vendor for details. While both provide information on applicable billing codes (CPTu00ae 75580 for Cleerly and HCPCS C9793 for inHEART), this does not allow for a comparative assessment of their actual cost or overall value proposition.
Enterprise Readiness
Cleerly ISCHEMIACleerly ISCHEMIA explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), providing clear assurances for data security and regulatory adherence. While inHEART Models is FDA-cleared and mentions SOC2 compliance, its HIPAA and BAA status are inferred rather than explicitly stated in the provided information, giving Cleerly a slight edge in transparency for enterprise readiness.
Innovation
inHEART ModelsinHEART Models demonstrates a higher degree of innovation by creating an 'AI-driven digital twin of the heart' for pre-procedural planning and optimization of complex cardiac ablation procedures. This direct application of AI to create highly detailed 3D models that seamlessly integrate with electroanatomic mapping systems offers a transformative approach to interventional cardiology. Cleerly's non-invasive FFR estimation is also innovative, but inHEART's digital twin concept for procedural guidance feels more groundbreaking.
Support & Docs
Cleerly ISCHEMIACleerly ISCHEMIA explicitly provides a 'Client Support' section on its website with a dedicated form for existing users to request technical support, indicating a structured approach to customer assistance. In contrast, inHEART Models primarily offers general contact information without detailing specific support channels or user-facing documentation, making Cleerly's support offerings appear more robust.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | inHEART Models |
|---|---|---|
| Name | Cleerly ISCHEMIA | inHEART Models |
| Company | Cleerly | inHEART |
| Description | Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. | inHEART Models is an AI-driven software that creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures. |
| Key Features | AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization (volume, type, location), Stenosis severity assessment, 3D digital models of coronary arteries, Comprehensive interactive web-based reports, Integration with PowerScribe via API | AI-driven digital twin of the heart, Automated segmentation of CT and MR images, Highly detailed, interactive 3D cardiac models, Pre-procedural planning and optimization of treatment strategies, Seamless integration with major electroanatomic mapping (EAM) systems (Cartou00ae, Rhythmiau2122, Ensiteu2122, Afferau2122), Potential to reduce VT procedure times by 60%, Potential to reduce VT recurrence rates by 38%, Cloud-based platform for interactive exploration |
| Primary Specialties | Cardiology, Radiology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and inHEART Models.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or inHEART Models
Backers
Who funded each tool's parent company.